Multi-Omics Approach to Dissect the Mechanisms of Rexinoid Signaling in Myoblast Differentiation

Area of Science:

• Regenerative Medicine
• Molecular Biology
• Epigenetics

Background:

• Stem cells are crucial for regenerative medicine, but efficient differentiation into muscle cells requires pharmacological control.
• Bexarotene, a retinoid X receptor (RXR) agonist used in cancer therapy, has shown promise in promoting skeletal muscle progenitor specification and differentiation.

Purpose of the Study:

• To elucidate the molecular mechanisms regulating rexinoid signaling during myogenic differentiation.
• To integrate multi-omics data for a comprehensive understanding of bexarotene's effects on myoblast differentiation.

Main Methods:

• Integrated RNA-sequencing (RNA-seq) with ChIP-sequencing (ChIP-seq) for various histone modifications (H4K8ac, H3K9ac, H3K18ac, H3K27ac, H3K27me) and p300.
• Performed data collection, validation, and omics integration analyses.

Main Results:

• Identified molecular pathways associated with differential gene expression and p300-mediated histone acetylation during bexarotene-induced myoblast differentiation.
• Revealed distinct chromatin states influenced by rexinoid signaling.

Conclusions:

• The integrated datasets provide a framework for understanding the interplay between signaling molecules, chromatin modifiers, and histone acetylation in muscle development.
• These findings support the repurposing of bexarotene and offer strategies for future research in myogenic regulation and muscle-specific gene targeting.